Alyeska Investment Group, L.P. Vertex Pharmaceuticals Inc Transaction History
Alyeska Investment Group, L.P.
- $25.4 Billion
- Q2 2025
A detailed history of Alyeska Investment Group, L.P. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 65,000 shares of VRTX stock, worth $25.2 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
65,000
Previous 431,804
84.95%
Holding current value
$25.2 Million
Previous $209 Million
86.18%
% of portfolio
0.11%
Previous 0.9%
Shares
7 transactions
Others Institutions Holding VRTX
# of Institutions
1,806Shares Held
239MCall Options Held
1.96MPut Options Held
1.13M-
Capital World Investors Los Angeles, CA28.7MShares$11.1 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$9.3 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.26 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.25 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.57 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $99.5B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...